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Abstract
Background: Group antenatal care has been successfully implemented around the world with suggestions of
improved outcomes, including for disadvantaged groups, but it has not been formally tested in the UK in the
context of the NHS. To address this the REACH Pregnancy Circles intervention was developed and a randomised
controlled trial (RCT), based on a pilot study, is in progress.
Methods: The RCT is a pragmatic, two-arm, individually randomised, parallel group RCT designed to test clinical
and cost-effectiveness of REACH Pregnancy Circles compared with standard care. Recruitment will be through NHS
services. The sample size is 1732 (866 randomised to the intervention and 866 to standard care). The primary
outcome measure is a ‘healthy baby’ composite measured at 1 month postnatal using routine maternity data.
Secondary outcome measures will be assessed using participant questionnaires completed at recruitment (baseline),
35 weeks gestation (follow-up 1) and 3 months postnatal (follow-up 2). An integrated process evaluation, to include
exploration of fidelity, will be conducted using mixed methods. Analyses will be on an intention to treat as
allocated basis. The primary analysis will compare the number of babies born “healthy” in the control and
intervention arms and provide an odds ratio. A cost-effectiveness analysis will compare the incremental cost per
Quality Adjusted Life Years and per additional ‘healthy and positive birth’ of the intervention with standard care.
Qualitative data will be analysed thematically.
(Continued on next page)
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: m.sawtell@ucl.ac.uk
1Social Research Institute, University College London, 27 Woburn Square,
London WC1H 0AA, UK
Full list of author information is available at the end of the article
Wiggins et al. BMC Health Services Research          (2020) 20:919 
https://doi.org/10.1186/s12913-020-05751-z
(Continued from previous page)
Discussion: This multi-site randomised trial in England is planned to be the largest trial of group antenatal care in
the world to date; as well as the first rigorous test within the NHS of this maternity service change. It has a
recruitment focus on ethnically, culturally and linguistically diverse and disadvantaged participants, including non-
English speakers.
Trial registration: Trial registration; ISRCTN, ISRCTN91977441. Registered 11 February 2019 - retrospectively
registered. The current protocol is Version 4; 28/01/2020.
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Background
Antenatal care is an important public health priority
which can promote good health both in pregnancy and
during the life-course of women and their children.
However, limitations to traditional models of care have
been documented [1]. Those from ethnic minority and
socially disadvantaged populations are known to experi-
ence both poorer access to, and quality of, antenatal care
[2]. Adverse pregnancy outcomes are linked with such
inequity [3].
Traditional antenatal care, delivered by midwives, is
on a one-to-one basis, but antenatal care delivered by
midwives on a group basis, has been implemented in
several countries with some success. Examples include
in the UK [4], Australia [5], the US [6], Iran [7] and else-
where. Evidence on group care shows increased women’s
satisfaction [7, 8] as well as potential better health and
safety outcomes [6, 8, 9]. Furthermore, delivery of group
antenatal care to vulnerable groups [10] has been shown
to be successful, with evidence of possible improved out-
comes for specific groups. Qualitative studies have also
indicated potential added advantages arising from having
a mixed group of participants [4].
What does group antenatal care involve?
In this model of antenatal care, health professionals
(usually, but not always, midwives) facilitate groups and
provide continuity of care to around 8–12 pregnant
women with similar estimated due dates. Group sessions
replace traditional one-to-one appointments and last
about two hours. Conventional facets of antenatal as-
sessment such as clinical checks are combined with in-
formation sharing and peer support through group
discussion led by participants. Group care was developed
to address some of the negative experiences of antenatal
care reported by women. These include problems that
are particularly challenging, in standard care, for more
vulnerable populations such as the very limited amount
of time that pregnant women spend with care givers and
lack of continuity of carer [11–13]. The opportunity
group care offers to build social support is likely to be
particularly beneficial for those whose existing support
networks are limited or non-optimal [14–16].
Why might group antenatal care be beneficial?
It is hypothesised that this group approach will promote
women’s empowerment, enabling them to take a more
active role in their care, supporting informed decision
making and facilitating more effective tailoring of their
antenatal care to their own requirements. The group ap-
proach encourages women to engage in self-monitoring
(i.e. checking their own urine and blood pressure) with
the aim of increasing their knowledge and confidence
[4]. In pregnancy, an increased sense of autonomy and
wider choice have been linked to a sense of greater con-
trol around birthing, which in turn can increase
women’s satisfaction with giving birth. Better birth expe-
riences have the potential to impact on the wellbeing of
women and their children [17–20]. Additionally, recent
evidence has shown that midwives trained to deliver
group antenatal care report satisfaction with working in
this way [21].
Outcomes of group antenatal care have not been
rigorously tested in the context of universal health care,
nor specifically in the UK within the context of the
NHS. Systematic reviews of group antenatal care con-
clude that there is a need for additional rigourous stud-
ies to determine whether previous positive findings are
applicable in different contexts [8, 10, 22]. The study de-
scribed here will aim to assess the clinical effectiveness
of the REACH Pregnancy Circles model of group ante-
natal care in a randomised controlled trial (RCT) with
integrated economic and process evaluations. The trial
will run in areas of the UK that are diverse (in terms of
ethnicity, culture and language) and/or economically dis-
advantaged. REACH Pregnancy Circles is a bespoke
model of group care which is designed to be responsive
to individual service needs and directly translates many
of the recommendations of the current UK national pol-
icy for maternity services [1].
This study is part of a NIHR-funded Programme
Grant for Applied Research, the REACH Pregnancy
Programme (Reference RP-DG-1108-10,049), which
aims to improve women’s access to, engagement with,
and experience of antenatal care. The Programme com-
prises four main components including this trial and a
two-stage feasibility/pilot study preceding it [4, 21, 23].
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This preparatory work, in line with best practice recom-
mendations [24], has enabled the research team to
understand and address the local and UK national chal-
lenges that any group-based model of antenatal care
needs to be tailored to meet, as well as to develop and
test the methods for the full trial.
Methods
Aims
The REACH Pregnancy Circles trial aims to assess the
following in ethnically, culturally and linguistically di-
verse and disadvantaged areas of the UK:
a) Whether Pregnancy Circles (group-based antenatal
care) improves the health of babies compared with
the standard individual model of antenatal care
b) Whether attending Pregnancy Circles improves
maternal outcomes such as empowerment and
post-natal psychological wellbeing, as well as in-
creasing women’s satisfaction with antenatal care
c) Cost-effectiveness, intervention mechanisms and
acceptability of Pregnancy Circles care to women
and staff and issues relevant to future sustainability
and wider implementation in the NHS.
Trial design
The REACH trial is a pragmatic, two-arm, individually
randomised, parallel group RCT. It involves an
intention-to-treat (ITT) comparison of the Pregnancy
Circles group antenatal care intervention with standard
care.
The trial includes an integral process and economic
evaluation. The process evaluation is a mixed method
study, aligned with Medical Research Council guidance
on process evaluations of complex interventions [25]. It
will include in depth exploration in three case study sites
involving questionnaires and semi-structured interviews
with service users, midwives and other stakeholders and
observations of antenatal care; as well as utilising cross
site monitoring data, reflective diaries and minutes from
meetings to explore facilitators and barriers to imple-
mentation, measure uptake, retention and fidelity to the
intervention.
The health economics evaluation will use a cost-
effectiveness analysis of the incremental cost per Quality
Adjusted Life Year (QALY) of the Pregnancy Circles
intervention compared with standard care. It will also
calculate the incremental cost per additional ‘healthy
and positive birth’ for group antenatal care compared to
control, using an innovative composite measure.
An internal pilot to check the feasibility of rates of re-
cruitment at scale will be conducted within the recruit-
ment period. Data from the internal pilot will be
presented to the Trial Steering Committee to support
decisions on trial processes and continuation.
Setting
The trial will be carried out within the maternity services
of around 12 NHS trusts in London and other areas of
England. A number of ‘Pregnancy Circles’ (i.e. one group
of women who have their antenatal appointments to-
gether) will be run within the catchment areas of each of
these trusts by midwives from the local service. It is an-
ticipated that around 7–14 Pregnancy Circles will be run
by each service.
Participants
Women who are currently pregnant and registering for
antenatal care, with any of the included maternity ser-
vices before 20 weeks of pregnancy (in order to capture
late bookers who are likely to be more vulnerable), will
be approached to take part in the trial. Fig. 1 shows par-
ticipant flow through the trial.
Eligibility criteria
Pregnant women will be eligible for inclusion in the
study if they:
 are 16 years old and over
 are part of the cohort of women cared for by the
team delivering the intervention (generally one
geographical area)
 have an estimated delivery date that fits with those
of a proposed group
 do not have a documented learning disability.
The trial is designed to be as inclusive as possible and
will include women who: are primiparous and multipar-
ous; “low” and “high” obstetric risk (e.g. diabetic); have
obstetric complications (e.g. multiple pregnancies); have
additional physical or social needs; do not speak English.
As a rule, women will be offered participation so that
they can make their own decision about this. Where spe-
cialist pathways are in place (e.g. diabetes, twins, teen-
agers etc.) referral to these services will be made.
Women can choose to attend Pregnancy Circles in
addition to specialist services. Local clinicians will make
decisions about offering participation to the most vul-
nerable women on a case by case basis (for example
where there are child protection concerns), depending
on local pathways for vulnerable women.
We learnt from the pilot study that managing the
number of languages spoken in a Pregnancy Circle is im-
portant. Therefore, before recruitment to each Preg-
nancy Circle starts, facilitating midwives at each site will
limit the number of different languages spoken within a
circle where interpreter support is required. Once
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recruiters have reached this ‘cap’ for each circle, any
subsequent pregnant woman who meets the inclusion
criteria but requires interpreter support for a language
different from those already included in a circle, will be
deemed ineligible.
Midwife facilitators will be eligible to take part if they
are employed by the maternity services involved in the
trial and have attended the study specific 1-day training
provided by the research team, or been trained by an ex-
perienced facilitating midwife.
Randomisation, blinding and bias
Randomisation will be carried out by recruiters in the
clinic, immediately following consent and baseline ques-
tionnaire completion, using a centralised online random-
isation system developed by the Pragmatic Clinical
Fig. 1 Participant Flow
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Trials Unit (PCTU) at Queen Mary, University of
London. Participants will be told their allocation status
straight away. Randomisation will be stratified by trial
site and how well a woman speaks English and partici-
pants will be randomised in equal numbers to interven-
tion and control arms. Women in the control arm will
proceed with standard care as per local procedures.
Those in the intervention arm will receive a welcome
pack detailing information on the venue and dates/times
and an outline of the content of all their Pregnancy
Circle sessions as well as contact details for their named
facilitating midwives.
The Trial Steering Committee (TSC), study statisti-
cians, health economists and chief investigator will be
blinded to treatment allocation during the trial. Some
members of the central research team, all members of
site teams and participants cannot not be blinded due to
the nature of the randomisation procedure and the
intervention.
There is a possible risk of facilitator bias as midwives
delivering the intervention may change their practice in
a standard care context as well as in the Pregnancy Cir-
cles, for example in terms of being more ‘woman-led’.
The chance of such contamination will be limited by the
fact that several key elements of the Pregnancy Circles
model cannot be reproduced in a standard care setting
(e.g. the social element, the self-checking, the extended
time of appointments, the degree of continuity of carer).
However, there remains a risk, the level and effects of
which will be assessed through the process evaluation.
Site selection and participant recruitment
The key issues, in terms of selection of potential trial
sites, is that they deliver maternity services in areas with
high levels of poverty and/or ethnic and language diver-
sity. Sites that meet this criterion will be asked to ensure
that, on average, they have sufficient numbers of ante-
natal bookings to support the recruitment target, based
on our learning from our pilot trial. This target is 24 re-
cruited participants per month randomised 1:1 across
trial arms. Aiming for an allocation of 12 to the inter-
vention arm allows for the possibility of attrition (e.g.
due to miscarriage) while still maintaining an optimum
number of 8–10 women per Pregnancy Circle.
Participant recruitment in the sites will be carried out
by staff funded by local Clinical Research Networks
(CRN) and will be conducted at either the antenatal
booking appointment and/or first dating-scan appoint-
ment. The decision on which appointment to target will
be based on how maternity services are arranged in the
trust with the aim of maximising the numbers of eligible
women research staff can access. These appointments
usually take place between 8 and 13 weeks of pregnancy
although sites will be encouraged to approach late
bookers up to 20 weeks pregnant.
Clinic lists will be scrutinised in advance of a clinic
and women on the list who appear to fit the inclusion
criteria will be identified. The patient information sheet
will be provided to these potential participants, either in
the post before they attend their booking or scan ap-
pointment, or while they are waiting in the clinic for
their appointment.
At the booking or scan appointment, the recruiter will
assess eligibility, take written informed consent and re-
quest completion of the baseline questionnaire. This will
be a paper document replacing a planned online version
provided via the electronic patient recorded outcome
tool (REDCap). The online version was found to be im-
practical when piloted in the clinic setting at the start of
recruitment. Randomisation will then be carried out.
Women who are unsure about participation will be in-
vited to take study documents away and have a few days
for consideration. Completion of documents and ran-
domisation can then be carried out, via liaison with re-
cruiters, face to face or by remote methods adhering to a
procedure that ensures best consent practice and GDPR
compliance. A £10 voucher will be provided to each re-
cruit as recognition of their time and effort.
Language support for recruitment will be provided for
women who meet the eligibility criteria who do not
speak English. Options for language support at each site
include some or all of the following: interpreters
employed by participating NHS trusts; researchers who
speak required languages; a phone interpreting service;
or informal support from family/other pregnant women.
Wherever possible women will be offered their preferred
route.
In advance of the study starting, a number of meetings
will be run by the research team for service side staff to
provide information and discuss support needed.
Intervention
The Pregnancy Circle model will consist of eight ante-
natal group sessions, reflecting the standard schedule for
antenatal care in the UK, each of which will last two
hours. Women will have the usual booking appointment,
one-to-one, and then the first Pregnancy Circle session
will take place at approximately 16 weeks of pregnancy.
Subsequent sessions will adhere to the standard NHS
antenatal care schedule for primigravida women [26]. In
addition, participants will be invited to a postnatal
reunion group held approximately 1 month after the
birth. Midwives will follow the usual NICE guidelines in
terms of referrals, safeguarding and the quality of mater-
nity care provided.
Two midwives (or in some cases a midwife and a ma-
ternity assistant) will facilitate each Pregnancy Circle
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group session. Face-to-face interpreters will attend each
session where required. Facilitating midwives will receive
a bespoke one-day training course and ongoing support,
from research midwives in the central research team, to
facilitate the Pregnancy Circles. A manual will be pro-
vided as a source of guidance for facilitators. Continuity
of carer will be aimed for, with the same two facilitators
planned for all the sessions for a Pregnancy Circle, with
one trained alternate in case of illness or annual leave,
and their Pregnancy Circles time will be included on the
service roster.
Each Pregnancy Circle session will begin with ‘self-care
monitoring activities’ (e.g. women testing their own blood
pressure and urine). Short (3–5min) one-to-one individ-
ual health checks will be carried out in the group space
with one of the midwives while the second midwife will fa-
cilitate the rest of the group engage in a group discussion.
The content of group discussions will follow the values
outlined in Fig. 2. They will be woman-led, with the facili-
tating midwives suggesting any essential topics that need
to be covered (in line with national and local clinical
guidelines). Women can request more privacy for one-to-
one time, as required. How and when the women’s
partners participate in the sessions will be decided by the
women themselves during the first circle.
A woman who wants to stop receiving group during
pregnancy will change to standard care. Facilitating mid-
wives will follow-up non-attenders to ascertain their rea-
sons for this, following the usual local protocol.
Patient and public involvement
Patient and Public involvement (PPI) to identify prior-
ities and preferences around antenatal care, the pro-
posed intervention and trial processes, was central to the
feasibility work that has shaped the trial. The full trial
mechanisms have been designed to ensure close working
with PPI co-investigators and representatives, who are
members of the trial management structures, on all is-
sues related to trial conduct. Furthermore, PPI co-
investigators will be involved in aspects of the qualitative
data analysis. The research team’s close contact with
local Maternity Voices Partnerships will be utilised to
consult more widely on specific issues as the trial pro-
gresses. PPI co-investigators and practitioners from trial
sites will be involved in creating and delivering the study
Fig. 2 Core Values of the Pregnancy Circles intervention
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dissemination plans. The central research team will
comprise both academics and health care practitioners.
Outcome measures
Potential outcomes and appropriate methods for utilis-
ing them were piloted [23].
The primary outcome is a ‘healthy baby’ composite
measured at 1 month postnatal using routine maternity
data. The composite is comprised of the following
four components:
1. Live baby (no stillbirth after 24 completed weeks of
pregnancy and no neonatal death within 28 days of
the birth)
2. Born at term (37 weeks and above)
3. Appropriate weight for gestational age (GROW
centile > 9.99 & < 90.01) [27]
4. Not admitted for neonatal intensive care
A baby is considered a ‘healthy baby’ if the answer to
all 4 components is ‘yes’.
The secondary outcomes are listed in Table 1, which
specifies the time points when collected and the stand-
ard measures being utilised, where appropriate.
The pilot trial showed that the completeness of the
routine data and the burden of questionnaires were
acceptable.
Data collection and management
Data management for the trial will be overseen by the
PCTU. Information related to participants will be kept
confidential and managed in accordance with the Data
Protection Act, NHS Caldecott Principles, The Research
Governance Framework for Health and Social Care, and
the conditions of research ethics committee approval.
Participant survey data will be captured on a REDCap
database which will be developed, supported and se-
curely hosted by the PCTU. REDCap is a secure web-
based tool that requires researchers to use a two-step
verification process to gain access.
The self-complete baseline questionnaire data col-
lected at recruitment will be entered onto REDCap by
the central research team following receipt of paper
baseline questionnaires sent securely from trial sites.
Questionnaires are identified by participant ID number
only and will be transported and stored separately from
any paperwork with identifiable information on, includ-
ing consent forms. All participant paperwork will be
stored in locked filing cabinets within locked rooms.
Participants will complete follow-up outcomes ques-
tionnaires at 35 weeks pregnant and 3 months postnatal.
Participants who provided an email address will be sent
a survey link via REDCap; paper versions with reply en-
velopes will be sent to participants without email
addresses. Where a woman requires language support, a
researcher will work with an interpreter to arrange com-
pletion over the phone or face-to-face in a setting of her
choice. In advance of contacting women about these
questionnaires, the research team will check with site
staff that there are no reasons why a woman should not
be approached. Non responders will be reminded once
electronically and then followed up on the telephone to
encourage completion. All women will be given a £10
voucher for each of the two outcomes questionnaires
they complete.
To access routine maternity data, researchers will
work with local sites for the transfer of electronic patient
record data, supplemented where there are gaps via ac-
cess to paper maternity notes. The research team will
supply the trust informatics team with a list of partici-
pant hospital numbers and study ID numbers, and a
proforma for required data. All anonymised electronic
routine patient data will be electronically transferred
from the participating trusts directly into the PCTU’s
safehaven as per the PCTU’s dedicated secure file trans-
fer protocol. Where there are gaps in the primary out-
come electronic data, local maternity staff who are
blinded to the allocation to study group will conduct an
audit by extracting data manually from the participants’
hospital paper records within the hospital setting. An
endpoint committee will be set up to assess any cases
where there are uncertainties around primary outcome
status. Members of the research team and a minimum of
two clinicians will be on this committee.
Intervention attendance will also be collected using re-
cords kept by facilitating midwives. Participants can
withdraw from either just the intervention or from the
whole study, this decision will be recorded. If the partici-
pant just withdraws from the intervention, they will be
followed-up. If they fully withdraw from the study, no
further data will be collected.
Audio recordings and transcripts of the research inter-
views will be stored on the secure servers at City, Uni-
versity of London or University of East London (UEL).
Confidentiality of personal data will be ensured through
the use of anonymisation and pseudonymisation
techniques.
Sample size
Originally at the onset of the trial, the primary outcome
was planned to be spontaneous vaginal birth (SVB). An
initial calculation for SVB as the primary outcome pro-
duced a sample size of 2120 women, assuming a differ-
ence of proportion of 70.2 to 77.5%, with 25% drop-out,
mean group size of 10 women, intra-cluster correlation
coefficient (ICC) of 0.1 and 80% power. However, the
ethics committee requested a change in primary out-
come as they had concerns that using SVB might
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influence midwives and women in mode of delivery deci-
sions to the detriment of health outcomes. As such, the
‘healthy baby’ composite was adopted instead.
Previous evidence relating to the variables in our
‘healthy baby’ composite suggests expected decreases in
rates of small for gestational age by between 20 and 30%
[38, 39], pre-term birth by 29–54% [6, 38, 40], and neo-
natal intensive care admissions by up to 65% [9]. We
therefore conservatively estimate that the rate of
unhealthy babies will decrease by 25%. Analyses of rou-
tine data from our pilot study NHS trust indicates that
31% of babies would experience these adverse outcomes.
A decrease of 25% equates to an 8%-point decrease to
23%. Correspondingly, this translates directly as an in-
crease in overall rates of healthy babies by 8% points
from 69 to 77%. Our Programme Steering Commit-
tee (PSC) and stakeholders have indicated that the
healthy baby composite and anticipated effect size
Table 1 Secondary outcomes for Pregnancy Circles Trial
Domain Validated measure (if
using)
Baseline First follow up
- 35 weeks
gestation
Birth –
routine
maternity
data
Second follow
up - 3months
postnatal
Women’s empowerment Pregnancy-related
Empowerment Scale (PRES)
[28]
✗ ✓ ✗ ✗
Women’s satisfaction with maternity care Friends and Family Test [29] ✗ ✓ ✗ ✓
Continuity of antenatal care ✓ ✓ ✗ ✗
Attendance at antenatal care ✓ ✓ ✓ ✗
Health service usage from patient records ✗ ✗ ✓ ✗
Health service usage (self-reported) ✗ ✓ ✗ ✓
Social support The Duke-UNC Functional
Social Support Questionnaire
[30]
✓ ✓ ✗ ✓
Self-efficacy Pearlin Mastery Scale [31] ✓ ✓ ✗ ✓
Prenatal stress Revised Prenatal Distress
scale [32]
✓ ✓ ✗ ✗
Spontaneous vaginal delivery (SVD) ✗ ✗ ✓ ✓
Caesarean delivery ✗ ✗ ✓ ✓
Infant birth weight, defined as low if less than 2500
g
✗ ✗ ✓ ✗
Place of birth ✗ ✗ ✓ ✗
Breast feeding initiation ✗ ✗ ✗ ✓
Breast feeding continuation and exclusivity ✗ ✗ ✗ ✓
Postnatal depression Edinburgh Postnatal
Depression Scale (EPDS) [33]
✗ ✗ ✗ ✓
Health Literacy Health Literacy Questionnaire
(HLQ) [34] (1 domain)
✗ ✓ ✗ ✗
Postnatal symptoms Postnatal symptoms checklist
(National Maternity Survey
2010) [35]
✗ ✗ ✗ ✓
Emotional wellbeing Short Warwick-Edinburgh
Mental Wellbeing Scale
(SWEMWBS) [36]
✓ ✓ ✗ ✗
Live baby (i.e. no stillbirth after 24 completed weeks
of pregnancy and no neonatal death within 28 days
of the birth)
✗ ✗ ✓ ✗
Born at term (37 weeks and above) ✗ ✗ ✓ ✗
Appropriate weight for gestational age (GROW
centile > 9.99 & < 90.01)
✗ ✗ ✓ ✗
Not admitted for neonatal intensive care ✗ ✗ ✓ ✗
Health related quality of life EQ5D-5 L [37] ✓ ✓ ✗ ✓
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reflects a clinically relevant and potentially practice-
changing outcome.
For the primary outcome of the healthy baby compos-
ite, to detect an increase in the proportion of babies
born “healthy” by 8% between the control and interven-
tion arm, with 90% power and a 5% significance level
would require at least 866 women per arm (1732 total).
This assumes an outcome proportion of 69% in the con-
trol arm and 77% in the intervention arm. Given that
the intervention is for group antenatal care, this sample
size calculation also accounts for clustering within the
intervention arm, with an ICC of 0.05, using mean group
sizes of 8 with cluster size variability assuming a Poisson
distribution for cluster size. This calculation was in-
formed by the findings of the pilot trial and given that
the primary outcome is from electronic routine mater-
nity data, it therefore assumes 10% drop-out in both
arms. When applying the updated sample size (1732
total) to SVB and the same difference of proportion a
power of 84.7% was calculated when using the updated
parameters (ICC of 0.05, mean group size of 8 and 10%
drop out).
Data analysis
A statistical analysis plan (SAP) will be written and
signed off before any allocation codes are provided to
the statistician analysing the trial and all those involved
in developing the analysis plan will remain blind to allo-
cation codes. Furthermore, the mechanism for dealing
with missing data, any sub-group analyses and any sensi-
tivity analyses will be outlined in the SAP. The analysis
plan will be reviewed by the independent statistician on
the TSC. The randomisation stratification factors will be
used as covariates in the models for the between treat-
ment analysis. If models are to be adjusted for other co-
variates, then these will be clearly stated in the statistical
analysis plan. All statistical tests will be two-tailed with
alpha = 0.05 and analyses will be performed on an ITT
basis. Baseline data, demographic and wellbeing infor-
mation will be described and summarised overall and by
treatment group.
The primary outcome data for the ‘healthy baby’
composite will be extracted via a postpartum mater-
nity records audit and be analysed using a logistic
random effects model with a random intercept esti-
mating a cluster specific effect in both arms. In the
intervention arm, within Pregnancy Circle correlation
will be accounted for and in the control arm each
participant will be modelled as a cluster of size 1. An
odds ratio and associated 95% confidence interval will
be presented. Secondary outcomes will be analysed
using the same mixed effects model accounting for
Pregnancy Circle correlation in the intervention arm
and will be presented with appropriate treatment
effect estimates (odds ratios, mean differences) and
associated 95% confidence intervals, based on the out-
comes themselves (i.e. binary/continuous scales).
All analyses will be performed based on available par-
ticipant data for the primary and secondary outcomes of
interest. There are no planned interim statistical ana-
lyses, with no highlighted stopping rules in relation to
efficacy in this trial.
Health economics evaluation
The economic evaluation will determine the cost-
effectiveness of Pregnancy Circles compared to standard
care for the period from conception until three months
postpartum, from a health and social cost perspective.
The cost of the intervention will include the cost of
training and the cost of the Pregnancy Circles. The latter
will be calculated based on forms completed by mid-
wives on the duration of the Pregnancy Circles, the
number of women in each circle and any additional time
required in the set up and running of the circle. In-
patient care in the antenatal and postnatal periods will
be collected from patient records in both trial arms.
Additional maternity and infant related resource use will
be provided via participant completed questionnaires at
35 weeks and three months postpartum as well as via
routine maternity data. Resource use will be costed
based on published sources and will be presented as de-
scriptive statistics for resources. Differences in costs be-
tween the two groups will be calculated using linear
regression, adjusting for randomisation stratification fac-
tors as covariates and a random intercept for Pregnancy
Circle. Ninety five percent confidence intervals will be
calculated from bootstrapped results with bias
correction.
The NICE recommendation that cost-effectiveness is
calculated as the cost per QALY gained [41], is challen-
ging in this study’s context. For the mother, the meas-
urement of QALYs is possible; but from the perspective
of the infant, the timing and method of measuring
QALYs is contentious and presents methodological diffi-
culties. The EQ-5D-5L has been included at baseline,
first and second follow up for the calculation of QALYs
in the mother, which will be calculated as the area under
the curve adjusting for baseline and randomisation
stratification factors with random intercept for Preg-
nancy Circle. Ninety five percent confidence intervals
will be calculated from bootstrapped results with bias
correction. In the pilot trial, the economic evaluation
used participant questionnaires to explore additional
utility measures. Building on this in this trial, women
will be involved in defining what a ‘positive and healthy
pregnancy and birth’ is, to enable a calculation of the in-
cremental cost per additional ‘healthy birth’ for Preg-
nancy Circles compared to standard care, using a new
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composite measure. The follow up data collected from
the pilot trial will be utilised in an assessment of the val-
idity of this new composite measure. In further develop-
ment work, which is on-going within this trial,
algorithms will be developed for how births might be
classified on a ‘healthy’ to ‘unhealthy’ continuum. The
mean incremental cost per ‘healthy birth’ and the mean
incremental cost per QALY will be reported. Cost-
effectiveness acceptability curves and cost-effectiveness
planes will be constructed based on bootstrapped data as
described above. The economic evaluation will handle
missing and censored data in line with the methods uti-
lised in the statistical analysis.
Process evaluation
The aim of the integral process evaluation is to help
understand the presence or absence of treatment effects
and to identify any unanticipated or unintended effects,
including adaptive systems effects. It will also explore
women’s experiences of antenatal care as well as poten-
tial contamination of the control group. The process
evaluation will employ some data collection across all
study sites, but in the main will concentrate on three
trial sites which will form case studies for more in-depth
data collection. These will be purposively selected with
the aim of achieving variation of cases.
Observations of pregnancy circles and standard care
Non-participant researcher observation will be con-
ducted, utilising a semi-structured observation proforma
to record the observations. In each of the case study
sites approximately three group sessions (across different
Pregnancy Circles) and three standard care consultations
will be observed. The aim of observations of the Preg-
nancy Circles is to capture data to support the measure-
ment of fidelity and for individual consultations to
facilitate the reporting of a description of standard care.
The Pregnancy Circles to be observed will be purpos-
ively selected for diversity of issues including: different
languages spoken in the group; partner presence; mix of
prima and multi-gravida; stage of pregnancy of the par-
ticipants; experience of the facilitators in delivering the
intervention. In addition, some non-case study sites
which warrant specific interest may also be approached
for observations. Standard care clinic appointments, con-
ducted by the midwife team delivering Pregnancy Cir-
cles, will also be purposively selected to ensure a range
of care typical to that area is reflected (e.g. community
vs hospital-based). Consent for the observations will be
obtained from staff, women and any partners present. If
anyone in the group care wishes to withdraw consent
their data will be excluded. The observation of standard
clinical care will not be carried out where women do not
give consent or where interpreting support is needed,
but not available.
Semi-structured interviews with study participants and key
stakeholders
A sample in each case study site of approximately seven
Pregnancy Circle and seven control participants will be
invited to participate in a one to one semi-structured
postnatal interview. The interviews will explore partici-
pant’s experiences and satisfaction with their antenatal
care and their perceptions of its effects. Sampling will be
purposive, to focus on understanding the experiences of
clinically and socially high risk and disadvantaged partic-
ipants. The views and experiences of women who re-
ceived language support as well as those who have
chosen to leave Pregnancy Circles to return to standard
care will also be sought. Participants will be interviewed
at a time and location of their choice, either over the
phone, at home or in a community venue with an appro-
priate level of privacy. Interviews will last about 30–60
min and will be audio recorded. Women participating in
these interviews will be given a £10 voucher as a ‘thank
you’ for their time and effort.
In the case study sites, a purposive sample of midwives
and key stakeholders (other relevant staff, recruiters,
clinical commissioners and patient group representa-
tives) will be offered the opportunity to take part in a
brief one to one or paired interview. These will explore
perceptions of issues such as delivery of Pregnancy Cir-
cles, retention in the groups, sustainability of this model
of care, and potential control group contamination. In
addition, some midwives and other key stakeholders
who are not part of the case studies but who are outliers
or practising in a unique way may also be invited to
interview.
Intervention utilisation, context and background
Monitoring data, including attendance data, will be col-
lected across all trial sites by midwives running the Preg-
nancy Circles. This will be utilised by the economic
evaluation and will also provide information for the
process evaluation regarding uptake and retention in the
intervention. The process evaluation will also draw on
the following documents to provide context and
background:
 Closing interviews with link researcher for each
study site;
 Field notes from researchers on training sessions run
for facilitating midwives;
 Facilitating midwives’ reflective forms;
 Research team processes and implementation
records.
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Process evaluation data analysis
Attendance data will be analysed with SPSS, providing
descriptive statistics. All qualitative observational data
and interview transcripts will be analysed thematically
using NVivo 12, and, with reference to the study logic
model (see Fig. 3). The logic model utilises a Context-
Mechanism-Intervention framework which draws on
realist evaluation principles. Triangulation across data
sources will be carried out. The Consolidated Frame-
work for Implementation Research will be used to in-
form the analysis in relation to implementation of this
model of care [42]. In addition, Normalisation Process
Theory [43] will inform the analysis of the potential for
future integration (‘normalisation’) of this model of care
into routine maternity practice within the NHS.
Governance and safety
Governance
This trial is one part of a wider NIHR programme grant.
The trial is sponsored by the UEL and monitored by
both the overall PSC as well as its own TSC. The TSC is
responsible for overseeing the trial to ensure; scientific
rigour, health service relevance, high ethical and re-
search governance standards. The independent TSC
members include a chairperson with maternity trials ex-
pertise, a statistician, an economist, a midwifery
representative and a PPI representative. The TSC de-
cided a separate data monitoring committee was not
needed and approved arrangements for any necessary
monitoring and reporting of interim data.
Safety
This trial is using a serious adverse event (SAE) system.
Definitions of SAEs in the study include: death of the
participant; life- threatening incident; persistent or
significant disability or incapacity; hospitalization for
duration of four or more nights; any other safety issue
considered medically important, including those affect-
ing the participant’s baby e.g. stillbirth/neonatal death,
congenital anomaly or birth defect.
SAEs will be assessed to decide if they are related
to the intervention or other trial procedures. If they
are the sponsor and research ethics committee will be
immediately informed. SAEs are periodically reported
to the TSC.
It is standard practice on maternity trials to exclude as
SAEs common events in pregnancy that are unlikely to
be related to any research procedures. This is particu-
larly relevant in trials of interventions, such as this one,
which have a low risk profile.
Fig. 3 Logic Model
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Discussion
The REACH Pregnancy Circles trial aims to assess
whether group-based antenatal care improves the health
of babies compared with the standard individual model
of antenatal care in ethnically, culturally and linguistic-
ally diverse and disadvantaged areas of the UK.
There are several identified/anticipated key challenges.
Firstly, recruiting sufficient participants. The pilot trial
that preceded this study demonstrated that the need to
recruit approximately 24 women every month, in order
to fill each monthly Pregnancy Circle, was likely to re-
quire the equivalent of one full-time member of staff
recruiting in each trial site for the whole period of re-
cruitment. The study is eligible for NIHR CRN support,
including from research midwives for recruitment, but
recruitment support is unlikely to be available at the
level required by the study. The research team therefore
will work creatively with local research departments to
ensure the capacity to successfully recruit the required
target numbers.
This trial has the added challenge of recruiting less
advantaged women as participants, including women
who do not speak English. While this is a strength of the
trial, and will ensure the intervention reaches the
intended population, it also presents practical recruit-
ment challenges. There was significant learning from the
pilot trial about how to improve recruitment practices,
including recruitment of more vulnerable groups. This
learning, which will be incorporated in the full trial in-
cluded: training recruiters; midwives and administrators
not to make assumptions about possible recruits; having
local troubleshooting and best practice sessions to en-
sure best coverage of the appropriate clinics for recruit-
ment; recruiting late bookers; other factors such as easy
access to interpreting services and having translations
prominently visible on the front of recruitment
materials.
While academic-practitioner collaboration in the con-
duct of RCTs is increasingly common, it remains rela-
tively unusual for allied health professionals, including
midwives, to be at the centre of such research. In this
study, as with others in the REACH programme [44],
the aim will be to have midwives as key collaborators at
both central research and site team level (for example as
site Principal Investigators). This will not only help to
maximise the rigour, relevance and success of the work
but also build research capacity in the midwifery profes-
sion and NHS trust maternity research teams.
The study started in September 2018 and is scheduled
to end in October 2021. At the time of submitting for
publication recruitment to the study was on pause due
to the restrictions on research in the NHS resulting from
the Covid19 pandemic, which may also impact on the
study end date.
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